Prediction Case File
YouTubeEvaluation Complete

Youtube market analysis

1 extracted signal · 1 resolved · 0 still active

DataDash profile imageDataDash24 Mar 2026, 22:20 UTC
Video preview for Youtube market analysis
Signals
1
Eligible signals in this source
Open
0
Still being tracked
Resolved
1
Evaluable outcomes
Successful
0
Canonical correct result
Failed
1
Canonical failed result
Resolved success
0%
Open and excluded signals omitted
Source overview

AI-generated source summary

The analysis focuses on Solana (SOL) using a 1D timeframe and Fibonacci retracement levels. The speaker notes a previous low at $68 and a subsequent move up to $98.8, representing a 40% increase. The key resistance area is identified around the $110-$120 zone. The speaker suggests waiting for a pullback to key support levels (like the 20-30% range of previous moves) before considering entry, emphasizing risk management and avoiding chasing price at resistance. The general sentiment is bullish for SOL, expecting further upside after potential consolidations.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  6. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

DataDash

Tracked signals
390
Historical success
37.5%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.